Evaluation of subclinical atherosclerosis in Turkish patients with acne vulgaris receiving systemic isotretinoin

© 2020 Wiley Periodicals LLC..

Studies conducted on isotretinoin have shown that it may indirectly lead to atherosclerosis. The objective of this study was to determine the effect of systemic isotretinoin on subclinical atherosclerosis. The present study included 63 patients with acne vulgaris who had used isotretinoin for 6 months. Glucose, insulin, and homeostatic model assessment of insulin resistance levels; body mass index; waist circumference; blood pressure; lipid profile; and lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), high-sensitivity C-reactive protein, and oxidized low-density lipoprotein (Ox-LDL) levels were compared in the patients at the initiation and discontinuation of the treatment. At the discontinuation of the treatment, LOX-1 and Ox-LDL levels showed a significant increase (P < .001 and P = .040, respectively). Differences in waist circumference were positively correlated with an increase in LOX-1 levels (r = .274; P = .030). Isotretinoin causes an increase in the levels of subclinical atherosclerosis markers. Although the present study sample size was small, we believe that caution should be exercised considering the risk of atherosclerosis during isotretinoin use in men with high waist circumference and cardiovascular risk factors; further studies are warranted in this regard.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:33

Enthalten in:

Dermatologic therapy - 33(2020), 3 vom: 03. Mai, Seite e13307

Sprache:

Englisch

Beteiligte Personen:

Karapınar, Tekden [VerfasserIn]
Polat, Mualla [VerfasserIn]
Buğdaycı, Güler [VerfasserIn]

Links:

Volltext

Themen:

Acne vulgaris
EH28UP18IF
Isotretinoin
Journal Article
Lectin-like receptor-1
Lipids
Oxidized low-density lipoprotein
Scavenger Receptors, Class E
Subclinical atherosclerosis

Anmerkungen:

Date Completed 14.05.2021

Date Revised 14.05.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/dth.13307

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM307485811